1SXP — SCHOTT Pharma AG & Co KgaA Share News
0.000.00%
Last trade - 00:00- €2.61bn
- €2.67bn
- €986.21m
Europe Research Roundup: Bunzl, Leroy Seafood Group, Shell
Schott Pharma jumps after FY results and 2025 outlook
Brief: Schott Pharma FY Net Profit Down 1% At EUR 150 Million
Factbox: IPOs stage fall comeback in Europe
Factbox: IPOs stage fall comeback in Europe
Brief: Gerresheimer, Stevanato Group And Schott Pharma Announce Strategic Industry "Alliance For RTU"
Europe Research Roundup: Air Liquide, Novo Nordisk, Syensqo
Gerresheimer jumps on Schott Pharma's Q3 beat
Brief: Schott Pharma Q3 Revenues Up 21% Y-o-y
Gerresheimer up as guidance confirmation reassures, analysts say
Europe Research Roundup: Centrica, Philips, Siemens AG
Europe Research Roundup: Air France-KLM, Shell, Watches of Switzerland
Brief: Schott Pharma Q2 Revenues Up 11% YoY To Eur 274 Mln
Vials maker Schott Pharma slides on 2025 profit warning
Brief: Schott Pharma AG & Co. KGaA See FY 25 Impacted By Slower Growth From Syringes
Stifel resumes Gerresheimer with 'buy' on strong GLP-1 exposure
Weight-loss drug deals to drive around 4% of Gerresheimer yearly growth, CEO says
Germany's Douglas shares trading below price guidance at IPO (updated)
Brief: Schott Pharma Says To Expand In U.S. With New Prefillable Syringe Manufacturing Facility In Wilson, North Carolina